AP Rated to Levophed® Unit-of-Use Bar-Coding
	Paddock Norepinephrine Bitartrate Injection, USP
	Strength	Size	NDC
	4 mg/4 mL	10 - 4 mL ampules	0574-0854-10

Use of Norepinephrine bitartrate injection during cyclopropane and halothane anesthesia is generally considered contraindicated. Norepinephrine should be used with extreme caution in patients receiving monoamine oxidase inhibitors (MAOI) or anti-depressants of the triptyline or imipramine types. Norepinephrine should not be given to patients who are hypotensive from blood volume deficits except as an emergency measure. Norepinephrine should also not be given to patients with mesenteric or peripheral vascular thrombosis unless the administration of Norepinephrine bitartrate injection is necessary as a life-saving procedure. Extravasation of norepinephrine into the tissues should be avoided and infusions should not be administered into the veins in the leg in elderly patients. Norepinephrine bitartrate injection contains sodium metabisulfite, a sulfite that may cause allergic-type reactions.